Correction: A bispecific antibody AP203 targeting PD-L1 and CD137 exerts potent antitumor activity without toxicity

J Transl Med. 2023 Aug 16;21(1):550. doi: 10.1186/s12967-023-04410-1.

Authors

Po-Lin Huang¹, Hung-Tsai Kan², Ching-Hsuan Hsu², Hsin-Ta Hsieh², Wan-Chien Cheng³, Ren-Yeong Huang³, Jhong-Jhe You⁴

Affiliations

¹ AP Biosciences, Inc., 17F., No. 3, Yuanqu St., Nangang Dist., Taipei, 115603, Taiwan. plhuang@apbioinc.com.
² AP Biosciences, Inc., 17F., No. 3, Yuanqu St., Nangang Dist., Taipei, 115603, Taiwan.
³ Department of Periodontology, School of Dentistry, Tri-Service General Hospital and National Defense Medical Center, Taipei, Taiwan.
⁴ AP Biosciences, Inc., 17F., No. 3, Yuanqu St., Nangang Dist., Taipei, 115603, Taiwan. jjyou@apbioinc.com.

No abstract available

Publication types

Published Erratum